Assessment of Motor Development With a Wearable in Rural and Low-income Settings

Launched by HELSINKI UNIVERSITY CENTRAL HOSPITAL · Mar 11, 2023

Keywords

ClinConnect Summary

The MaMa study is a clinical trial that aims to understand how a wearable device can help track motor development in infants living in rural and low-income areas. The study will involve around 100 infants, who will be observed at home from the age of 6 months to 18 months. Researchers will look closely at how these infants move and develop, and then assess their overall development when they reach 18 to 24 months old. This will help determine if the wearable device is effective in monitoring infant growth and motor skills.

To participate in the study, infants must be born at term (between 35 and 42 weeks of pregnancy) and be between 6 and 18 months old at the start of the study. It’s important that the mother or caregiver can speak Chi-Chewa, Chi-Yao, or English and that they live in the Lungwena Health Centre area. If you join the study, you can expect regular check-ins at home where researchers will measure your child's development. This study is currently recruiting participants, and it could provide valuable insights into how to support infant development in similar communities.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • A documented birth date
• • Birth at about term age, i.e. between 35 and 42 gestation weeks
• • Mother's ability to speak fluently Chi-Chewa, Chi-Yao or English
• • Permanent resident of Lungwena Health Centre catchment area
• • Availability and willingness of the mother and infant during the period of the study
• • Signed or thumb-printed informed consent by the caregiver of the infant
• Exclusion Criteria:
• • Very early birth (at 7th month or earlier) based on mother's information
• • Infant's congenital malformation or severe illness as judged clinically by a study nurse